8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)

January 20, 2015 (January 20, 2015)

Diversicare Healthcare Services, Inc.

(Exact name of registrant as specified in its charter)

Delaware	001-12996	62-1559667
(State or other jurisdiction of incorporation)	(Commission File Number)	(Employer Identification Number)

1621 Galleria Boulevard Brentwood, TN 37027-2926

(Address of principal executive offices)

(615) 771-7575

(Registrant's telephone number, including area code)

Not applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 7.01. Regulation FD Disclosure.

On January 20, 2015, Diversicare Healthcare Services, Inc. presented at the Noble Investor Conference in Port St. Lucie, Florida. The presentation given by the Company at the conference is set forth as Exhibit 99.1.

Item 9.01.    Financial Statements and Exhibits.

(d) Exhibits

NumberExhibit

99.1        Noble Investor Conference Presentation - January 20, 2015.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Diversicare Healthcare Services, Inc.

By:    /s/ James R. McKnight, Jr.    

James R. McKnight, Jr.

Chief Financial Officer

Date:    January 20, 2015

EX-99.1

Nasdaq: DVCR Noble Investor Conference January 20, 2015

Nasdaq: DVCR Forward-looking statements made in this presentation involve a number of risks and uncertainties, but not limited to, our ability to successfully operate the new nursing centers in Alabama, Kansas, Kentucky, Missouri, Ohio, and Indiana, our ability to increase patients served at our renovated centers, changes in governmental reimbursement, government regulation, the impact of the recently adopted federal health care reform or any future healthcare reform, any increases in the cost of borrowing under our credit agreements, our ability to comply with covenants contained in those credit agreements, the outcome of professional liability lawsuits and claims, our ability to control ultimate professional liability costs, the accuracy of our estimate of our anticipated professional liability expense, the impact of future licensing surveys, the outcome of proceedings alleging violations of state or Federal False Claims Acts, laws and regulations governing quality of care or other laws and regulations applicable to our business including laws governing reimbursement from government payers, impacts associated with the implementation of our electronic medical records plan, the costs of investing in our business initiatives and development, our ability to control costs, changes to our valuation of deferred tax assets, changes in occupancy rates in our centers, changing economic and competitive conditions, changes in anticipated revenue and cost growth, changes in the anticipated results of operations, the effect of changes in accounting policies as well as other risk factors detailed in the Company's Securities and Exchange Commission filings. The Company has provided additional information in its Annual Report on Form 10-K for the fiscal year ended December 31, 2013, as well as in other filings with the Securities and Exchange Commission, which readers are encouraged to review for further disclosure of other factors that could cause actual results to differ materially from those indicated in the forward-looking statements. Forward-Looking Statements 2

Nasdaq: DVCR Leading Skilled Nursing Provider Compelling Demographic Trends Management’s Strategic Vision Yielding Results Improving Patient Quality Measures, Census And Skilled Mix Demonstrated Ability To Grow And Enhance Portfolio Positively Trending Financial Results Investment Highlights 3

Nasdaq: DVCR • Joined Diversicare in 2013 • 20+ years of experience in the LTC industry • Previous senior leadership positions at: ‒ Golden Living • Licensed Physical Therapist Executive Leadership • Joined Diversicare in 2012 • 10 Years of senior finance positions in the healthcare industry • Previous senior leadership positions at: ‒ NuscriptRX ‒ Take Care Health Systems ‒ I-TRAX, Inc. (CHD Meridian) • Joined Diversicare in 2010 • 25 Years+ of experience in the LTC industry • Previous senior leadership positions at: ‒ Beverly ‒ Living Centers of America ‒ Skilled Healthcare • SNF – Rehab - Hospice Jay McKnight Chief Financial Officer Kelly Gill CEO, President & Director Leslie Campbell Chief Operating Officer 4

Nasdaq: DVCR FY13 Revenue $260M – Q3 FY14 Annualized Run Rate $361M As of today – 51 SNF’s, 1 ALF – 6,321 Licensed Beds - 9 States Headquartered in Brentwood, TN NE CO OK LA FL (1) IA IL KS (5) OH (6)IN (1) MO (3) AR KY (11) TN (5) PA MS AL (7) SC NC GA VA WV TX (13) Diversicare at a Glance 5

Nasdaq: DVCR • Operating since 1989 • Traded on NASDAQ: DVCR • Publicly traded since 1994 • Added to Russell Microcap Index in 2014 • 52 week range $4.88 – $13.32 • Highest 2014 share price growth in peer group with 109% • Historically paid $0.22 annual dividend 6 Company Profile

Nasdaq: DVCR 7 Long Term Care Industry Overview • Compelling Demographic Trends • High Quality Clinical Outcomes • Relative Low Cost of Care

Nasdaq: DVCR 8 Compelling Industry Demographics Risi n g Deman d St able Su p pl y Sources: AHCA, CMS OSCAR Data and US Census Bureau, US Administration on Aging 15,000 15,500 16,000 16,500 17,000 2000 2002 2004 2006 2008 2010 2012 2014 Number of Skilled Nursing Facilities 0 20 40 60 80 100 1990 2000 2010 2020E 2030E 2040E 2050E Age 65+ Population (in millions)

Nasdaq: DVCR 9 • Long term care spending continues to increase ‒ Medicare and Medicaid expenditures for SNFs expected to grow 85% from 2013 to 2023 ‒ Annual spending on older adults is expected to increase 250% by 2040 Sources: Medpac and US HHS Department Compelling Industry Demographics $20.0 $30.0 $40.0 $50.0 $60.0 $70.0 $80.0 $90.0 2010 2011 2012 2013 2014E 2015E 2016E 2017E 2018E 2019E 2020E 2021E 2022E 2023E Medicare and Medicaid SNF Spending (in billions) Medicare Medicaid

Nasdaq: DVCR 10 Relative Cost Per Case of Treatment Across Post-Acute Care Providers Sources: Medpac and US HHS Department $0 $20 $40 $60 $80 $100 $120 Stroke Hip Fracture Joint Replacement Respiratory w/ Vent Tracheotomy w/ Vent $9 $11 $6 $8 $10 $34 $18 $17 $26 $26 $31 $45 $67 $75 $115 SNF IRF LTAC SNFs are recognized as high quality, low cost provider of institutional post-acute care

Nasdaq: DVCR 11 Company Overview • Mature Company • Provides a full spectrum of post-acute healthcare services • Robust operating platform capable of significant growth expansion

Nasdaq: DVCR Investments made in internal improvements and scalability position Diversicare for external growth Launched Q3 2010 Today Expanded Focus Now On Portfolio Growth Retooling: Areas of Focus Platform Development Operational Improvement Facility Renovations Key Strategic Accomplishments 12

Nasdaq: DVCR Implement an Electronic Medical Record (EMR) Solution Centralization of Key Processes People – Processes – Resources Completed – Company repositioned for rapid growth Platform Development and Operational Improvements 13

Nasdaq: DVCR 14  $29.1 Million Invested Since 2010  Renovations Completed At 17 Facilities  2 Facilities In Progress  Others In Development Average Occupancy Improvement: 229 BPS Facility Renovations

Nasdaq: DVCR 15 Key Results and Outcomes • Improved Quality Measures • Improved patient mix and reimbursement rates • Improved operating and G&A leverage • Demonstrated growth through acquisitions

Nasdaq: DVCR 0% 10% 20% 30% 40% 50% 60% 1 Star 2 Star 3 Star 4 Star 5 Star December 2008 September 2014 90.0% of Diversicare centers were rated 4 or 5 Star in terms of Quality Measures compared to 29.2% as of December 2008 Results: Significantly Improved Five Star Quality Measures 16

Nasdaq: DVCR 0% 10% 20% 30% 40% 50% 60% 1 Star 2 Star 3 Star 4 Star 5 Star For-Profit Peers DVCR 90% of Diversicare centers were rated 4 or 5 Star in terms of Quality Measures compared to 78% of for-profit peer group. Results: 5 Star Quality Measures Relative to For-Profit Peer Group 17 3.8 3.9 4 4.1 4.2 4.3 4.4 4.5 Overall QM Rating 4.46 DVCR Industry For-Profit Not-For-Profit Diversicare is an industry leader in Quality Measures.

Nasdaq: DVCR Skilled Care and Marketing Initiatives: • 24 Hour RN coverage with specialized clinical capability • Clinical programs drive higher acuity and favorable reimbursement trends • Facility based sales representatives deploy centrally managed business development activities • Clinical programs can be customized for physician needs Results: Improved Patient Mix 383 382 374 441 500 563 544 0 100 200 300 400 500 600 Q1 13 Q2 13 Q3 13 Q4 13 Q1 14 Q2 14 Q3 14 Medicare Avg Daily Census 110 89 100 114 150 138 152 0 20 40 60 80 100 120 140 160 Q1 13 Q2 13 Q3 13 Q4 13 Q1 14 Q2 14 Q3 14 Managed Care Avg Daily Census 18

Nasdaq: DVCR $380 $430 $480 Q3 '10 Q4 '10 Q1 '11 Q2 '11 Q3 '11 Q4 '11 Q1 '12 Q2 '12 Q3 '12 Q4 '12 Q1 '13 Q2 '13 Q3 '13 Q4 '13 Q1 '14 Q2 '14 Q3 '14 $388 $447 Medicare Rate Per Day Medicare Rate Per Day RUGS IV Final Rule Impact A – Resulting from a 2% decrease in rates as a result of sequestration beginning April 1, 2013. Results: Rate Increases Driven By Higher Acuity • Medicare rate growth driven by acuity • 13.3% Increase from FY10 Q3 to FY14 Q3 • 3.6% CAGR 19 A

Nasdaq: DVCR • Medicaid rates driven by acuity • 9.1% Increase from FY10 Q3 to FY14 Q3 • 2.2% CAGR Results: Rate Increases Driven By Higher Acuity 20 $140 $145 $150 $155 $160 $165 Q3 '10 Q4 '10 Q1 '11 Q2 '11 Q3 '11 Q4 '11 Q1 '12 Q2 '12 Q3 '12 Q4 '12 Q1 '13 Q2 '13 Q3 '13 Q4 '13 Q1 '14 Q2 '14 Q3 '14 $148 $161 Medicaid Rate Per Day Medicaid Rate Per Day

Nasdaq: DVCR Results: Growth in Operated Facilities • Our ability to integrate facilities onto our platform is proven by our continuous growth and early accretion of new facilities. 21 25 30 35 40 45 50 55 2012 Q1 2012 Q2 2012 Q3 2012 Q4 2013 Q1 2013 Q2 2013 Q3 2013 Q4 2014 Q1 2014 Q2 2014 Q3 2014 Q4 32 52

Nasdaq: DVCR Acquisitions are Accretive to earnings within a quarter of acquisitions date – the exceptions being development opportunities like new construction, major renovations, etc. Demonstrated Platform Scalability by increasing revenues with a resulting reduction in G&A expense as percentage of revenue New Facility Integration, including EMR, implemented during the first quarter of operations at new facilities Results: Impact Of New Centers 22

Nasdaq: DVCR Results: Revenue Impact of Acquisitions * Same-store group represents all centers not included in respective acquisition groups above. Does not include new acquisitions finalized subsequent to Q3 2014. 23 $0 $10 $20 $30 $40 $50 $60 $70 $80 $90 $100 Q1 '13 Q2 '13 Q3 '13 Q4 ’13 Q1 ’14 Q2 '14 Q3 '14 Quarterly Revenue in Millions 2014 Acquisitions (7) 2013 Acquisitions (10) Same-store group*

Nasdaq: DVCR Q3 2014 vs. Q2 2014 (in millions) Q3 ’14 Q2 ’14 Q3 ’14 Q2 ’14 Q3 ’14 Q2 ’14 2014 Acquisitions (7) $10.0 $3.3 $8.0 $2.3 $2.0 $1.0 2013 Acquisitions (10) $18.6 $18.6 $15.6 $15.3 $3.0 $3.3 Total for all acquisitions $28.6 $21.9 $23.6 $17.6 $5.0 $4.3 Same-store group* $61.7 $60.4 $49.4 $47.1 $12.3 $13.3 Consolidated total $90.3 $82.3 $73.0 $64.7 $17.3 $17.6 Revenue Operating Expense Operating Profit *Same-Store group represents all nursing centers not included in the respective acquisition groups above. Results: New Centers and Same-Store 24

Nasdaq: DVCR Results: Revenue Growth and Operating Leverage • Continued Company-wide cost reduction efforts in place o Diligent vendor management and product selection criteria o Centralized purchasing functions drive consistency through all facilities 0% 5% 10% 15% 20% 25% $30 $40 $50 $60 $70 $80 $90 $100 Q1 '13 Q2 '13 Q3 '13 Q4 '13 Q1 '14 Q2 '14 Q3 '14 Revenue Operating Margin 25

Nasdaq: DVCR • Continued G&A reduction efforts in place o Right-sized overhead structure for new portfolio o Centralized core functions to leverage skilled teams • Savings from G&A reductions funded strategic investments • G&A increased in first half 2013 due to acquisition activity 8.5% 6.2% 5.0% 6.0% 7.0% 8.0% 9.0% 10.0% Q1 '13 Q2 '13 Q3 '13 Q4 '13 Q1 '14 Q2 '14 Q3 '14 G&A Expense as a % of Revenue Results: Improving G&A Leverage 26

Nasdaq: DVCR 27 Current Areas of Focus • Continuous quality improvement • Enhancing existing portfolio • Growth through accretive acquisitions

Nasdaq: DVCR Continuous improvement of Quality Measures Continue to drive volume of patients served Improve skilled mix / provide high-acuity services Ongoing renovations of existing facilities Continue to Enhance Existing Portfolio 28

Nasdaq: DVCR Stated goal to double the Company within 5 years of Q3 2013 to 80 facilities Target: 5-10 new facilities per year Active pipeline and buyer friendly market Expanded operating infrastructure = Scalability Structure flexibility = Several sources of financial capacity Portfolio Growth 29

Nasdaq: DVCR Today2010 Portfolio has grown by more than 60% after divestitures • Exited Arkansas and West Virginia • Entered Missouri, Kansas, and Indiana • Added Facilities in Ohio, Alabama, and Kentucky Deepen and Expand Existing Footprint 30 OH (6) FL (1) IN (1) AL (7) KS (5) MO (3) TX (13) AR (12) TX (13) OH (1) AL (6) FL (1) WV (2)

Nasdaq: DVCR • Full Ownership Of Assets • Participate In Value Appreciation • Enhance Facility Ownership Fee-Simple Acquisitions • Minimal Capital Required • Leverage Turnaround Capabilities • Leverage Strong REIT Relationships Assumption of Long-Term Operating Leases 2010 Today 20% 25% 80% 75% Flexible Structure Broadens Pipeline 31 Acquisition Types

Nasdaq: DVCR 32 Summary • Improved operational and financial results • Attractive investment dynamics • Repositioned for the future

Nasdaq: DVCR Key Financial and Operating Statistics Q3 2013 Q4 2013 Q1 2014 Q2 2014 Q3 2014 Average Daily Census 3,460 3,880 3,986 4,090 4,414 Total Average Daily Census – Medicare & Managed Care 474 555 650 701 696 Skilled Mix % 13.7% 14.3% 16.3% 17.1% 15.7% Occupancy (Available Beds) 80.5% 80.3% 80.3% 81.3% 81.3% Medicare Rate Per Day $429.23 $435.63 $437.64 $438.46 $446.75 Medicaid Rate Per Day $156.85 $158.51 $157.83 $158.47 $161.43 Revenue (Millions) $64.6 $75.7 $77.8 $82.3 $90.3 Facility Level Operating Profit $10.4 $14.6 $15.0 $17.6 $17.3 G&A % of Revenue 7.7% 6.8% 6.6% 6.5% 6.2% Adjusted EBITDAR $4.8 $8.1 $7.9 $10.8 $10.1 Adjusted EBITDA $(0.1) $2.4 $1.9 $4.6 $3.2 33

Nasdaq: DVCR Leading Skilled Nursing Provider Compelling Demographic Trends Management’s Strategic Vision Yielding Results Improving Patient Quality Measures, Census And Skilled Mix Demonstrated Ability To Grow And Enhance Portfolio Positively Trending Financial Results Investment Highlights 34

Nasdaq: DVCR Appendix A: Reconciliation of Net Income to Adjusted EBITDA and Adjusted EBITDAR (a) Represents the separation and related costs of Diversicare Healthcare Services, Inc. (b) Represents non-recurring costs associated with acquisition-related transactions. (c) Represents the negative EBITDA associated with the new facility and venture start-ups of Diversicare Healthcare Services, Inc. (d) Represents non-recurring restructuring costs associated with the disposition of Arkansas. Q3 2013 Q4 2013 Q1 2014 Q2 2014 Q3 2014 (Unaudited) (Unaudited) (Unaudited) (Unaudited) (Unaudited) Net income (loss) (4,765)$ (571)$ (1,045)$ 1,101 4,147 Loss (income) from discontinued operations 2,444 (352) 612 (128) (3,928) Income tax provision (benefit) (1,374) 52 (365) 754 147 Interest expense 855 891 892 949 916 Depreciation 1,634 1,792 1,735 1,705 1,812 EBITDA (1,206) 1,812 1,829 4,381 3,094 EBITDA adjustments: Separation and related costs (a) - - - - - Acquisition related costs (b) 123 104 110 207 124 New facility start-up negative EBITDA (c) 115 - - - - Restructuring (d) 944 502 - - - Adjusted EBITDA (24) 2,418 1,939 4,588 3,218 Add: lease expense 4,817 5,644 5,967 6,251 6,876 Adjusted EBITDAR 4,793$ 8,062$ 7,906$ 10,839 10,094 35